PMID- 36929409 OWN - NLM STAT- MEDLINE DCOM- 20230508 LR - 20230508 IS - 1433-8726 (Electronic) IS - 0724-4983 (Linking) VI - 41 IP - 4 DP - 2023 Apr TI - Robot-assisted simple prostatectomy for prostates greater than 100 g. PG - 1169-1174 LID - 10.1007/s00345-023-04326-x [doi] AB - PURPOSE: Efforts are ongoing to treat severe benign prostatic hyperplasia as traditional endoscopic treatment options are often difficult to perform and associated with significant complications. This manuscript highlights our initial experience of robot-assisted simple prostatectomy [RASP] with minimum a year follow-up. We also compared our outcomes with published literature. METHODS: After an Institution Review Board approval, we gathered data of 50 cases of RASP between Jan 2014 and May 2021. Patients with prostate volume > 100 cc [calculated from magnetic resonance imaging (MRI)] and prostate biopsy confirmed benign prostate were candidates for RASP. Patients underwent RASP via transperitoneal route either by suprapubic or trans-vesical approach. Preoperative demographics, peri-operative parameters and post-operative parameters such as hospital stay, catheter removal, urinary continence and uroflow were recorded in standard database and presented as descriptive statistics. RESULTS: Patients presented with a baseline median International Prostate Symptom Score (IPSS) of 23 (inter-quartile range (IQR) 21,25) and a median PSA of 7.7 ng/ml (IQR 6.4,8.7). Median preoperative prostate volume was 167 ml (IQR, 136,198 ml). Median console time was 118 min, and median estimated blood loss was 148 ml (IQR 130, 167 ml). None of our cohort needed intraoperative transfusion, conversion to open surgery or developed any complications. Median time to Foley removal was 10 days (IQR 8,12). Significant drop in the IPSS score and improvement in Qmax was noted over the period of follow-up. CONCLUSION: RASP is associated with considerable improvements in urinary symptoms. However, comparative studies with endoscopic treatment options of large prostatic adenomas are warranted and ideally include cost analysis of different procedures. CI - (c) 2023. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature. FAU - Wagaskar, Vinayak G AU - Wagaskar VG AD - Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA. FAU - Zaytoun, Osama AU - Zaytoun O AD - Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA. AD - Department of Urology, Alexandria, Egypt. FAU - Kale, Priyanka AU - Kale P AD - Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA. FAU - Pedraza, Adriana AU - Pedraza A AD - Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA. FAU - Haines, Kenneth 3rd AU - Haines K 3rd AD - Department of Pathology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, New York, NY, 10029, USA. FAU - Tewari, Ash AU - Tewari A AD - Department of Urology, Icahn School of Medicine at Mount Sinai, The Mount Sinai Hospital, 1425 Madison Avenue, New York, NY, 10029, USA. Ash.tewari@mountsinai.org. LA - eng PT - Journal Article DEP - 20230316 PL - Germany TA - World J Urol JT - World journal of urology JID - 8307716 SB - IM MH - Male MH - Humans MH - Prostate/diagnostic imaging/surgery/pathology MH - *Robotics/methods MH - Prostatectomy/methods MH - Treatment Outcome MH - *Prostatic Hyperplasia/complications MH - *Robotic Surgical Procedures/methods OTO - NOTNLM OT - Benign prostatic hyperplasia OT - Prostatectomy OT - Urinary symptoms EDAT- 2023/03/18 06:00 MHDA- 2023/05/08 06:41 CRDT- 2023/03/17 10:05 PHST- 2022/09/17 00:00 [received] PHST- 2022/12/30 00:00 [accepted] PHST- 2023/05/08 06:41 [medline] PHST- 2023/03/18 06:00 [pubmed] PHST- 2023/03/17 10:05 [entrez] AID - 10.1007/s00345-023-04326-x [pii] AID - 10.1007/s00345-023-04326-x [doi] PST - ppublish SO - World J Urol. 2023 Apr;41(4):1169-1174. doi: 10.1007/s00345-023-04326-x. Epub 2023 Mar 16.